Evonik Industries AG 2015 AR2
The report highlights a successful fiscal year 2015 for Evonik, with total sales increasing by 5 percent to €13,507 million and adjusted EBITDA rising by 31 percent to €2,465 million. The company completed its strategic reorganization into a decentralized management holding structure with three independent chemical segments. Evonik successfully completed major growth investments, including a new lysine facility in Brazil and expanded oil additive capacity in Singapore. In sustainability, the company achieved its On Track 2.0 efficiency targets, reduced its accident frequency rate to 1.0, and was included in the Euronext Vigeo Eurozone 120 index.
Company: Evonik Industries AG
Sector: Manufacturing
Country: Germany
Year: 2015
Type: AR2
Pages: 230
Back to company
Evonik Industries AG
Annual Report
The report highlights a successful fiscal year 2015 for Evonik, with total sales increasing by 5 percent to €13,507 million and adjusted EBITDA rising by 31 percent to €2,465 million. The company completed its strategic reorganization into a decentralized management holding structure with three independent chemical segments. Evonik successfully completed major growth investments, including a new lysine facility in Brazil and expanded oil additive capacity in Singapore. In sustainability, the company achieved its On Track 2.0 efficiency targets, reduced its accident frequency rate to 1.0, and was included in the Euronext Vigeo Eurozone 120 index.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2015
Reporting Period
Jan 1, 2015 - Dec 31, 2015
Fiscal Year
2015
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Standard
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Women on Board
Women in Management
Workplace Fatalities
Employees